Discover 186 paid clinical trials in North Dakota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
North Dakota offers many paid research opportunities statewide, giving healthy volunteers and individuals with specific health needs access to a wide range of clinical studies. Key cities like Fargo, Bismarck, and Grand Forks are home to research centers actively recruiting participants, offering access to the latest treatments and medical advancements.
Filter
1
Filter results
Results: 186
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: Boston MA, Waterford CT, Guilford CT, New Haven CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase3, Recruiting
Active & Responsive
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: Boston MA, Lake Success NY, Mount Kisco NY,
Sponsor: Cleerly, Inc.
Sex: All
Age: 55+
Code: NCT06112418
Recruiting
Active & Responsive
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Location: Erie PA, Madison WI, Fargo ND, The Woodlands TX,
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 50+
Code: NCT06924021
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
for
Knee Injuries, Pain, Postoperative, Opioid Use
Location: Fargo ND
Sponsor: Sanford Health
Sex: All
Age: 18 - 70+
Code: NCT03858231
Recruiting
Active & Responsive
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
for
Atopic Dermatitis (AD), Psoriasis (PsO)
Location: Fargo ND, Dallas TX
Sponsor: LAPIX Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06982352
Phase1, Recruiting
Active & Responsive
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)